You have 9 free searches left this month | for more free features.

oral immunomodulator

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic acid, Low-dose aspirin)

Recruiting
  • Hydroxychloroquine
  • Assiut, Egypt
    Abdel-rahman Mahmoud Mohammed
Jul 21, 2021

Asthma in Children, Asthma Trial (Blood sample, Expectoration, Nasopharyngeal swab)

Not yet recruiting
  • Asthma in Children
  • Asthma
  • Blood sample
  • +2 more
  • (no location specified)
Sep 18, 2023

COVID-19 Trial in Yogyakarta, Kota Jkt Utara (AD17002 + Formulation buffer, Placebo)

Not yet recruiting
  • COVID-19
  • AD17002 + Formulation buffer
  • Placebo
  • Yogyakarta, Daerah Istimewa Yogyakarta, Indonesia
  • +2 more
Sep 13, 2022

Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Multipeptide plus XS15
  • Tübingen, BW, Germany
    University Hospital Tübingen
May 9, 2022

Epithelial Ovarian Cancer Trial in Jakarta, Jakarta Pusat (Vitamin D, Placebo)

Recruiting
  • Epithelial Ovarian Cancer
  • Vitamin D
  • Placebo
  • Jakarta, DKI Jakarta, Indonesia
  • +2 more
Jun 18, 2022

Coronavirus Disease 2019 (COVID-19) Trial in United States (CD24Fc, Placebo)

Completed
  • Coronavirus Disease 2019 (COVID-19)
  • Jacksonville, Florida
  • +9 more
Oct 13, 2021

Solid Tumor, Adult Trial in Geneva, Zürich (MVX-ONCO-2)

Withdrawn
  • Solid Tumor, Adult
  • MVX-ONCO-2
  • Geneva, Switzerland
  • +1 more
Jan 27, 2023

COVID-19 Trial in Viña Del Mar (MC 3x3, Placebo)

Not yet recruiting
  • COVID-19
  • MC 3x3
  • Placebo
  • Viña Del Mar, Valparaiso, Chile
    Hospital Gustavo Fricke
Jul 18, 2022

Primary Sjögren's Syndrome Painful Sensory Neuropathies Trial in Strasbourg (Privigen® 100mg/ml at the dose of 2g/kg of body

Recruiting
  • Primary Sjögren's Syndrome Painful Sensory Neuropathies
  • Privigen® 100mg/ml at the dose of 2g/kg of body weight
  • NaCl 0,9%
  • Strasbourg, France
    University Hospital, Strasbourg, france
Jul 7, 2022

Crohn Disease Trial in Philadelphia (Vancomycin, Neomycin, Ciprofloxacin)

Completed
  • Crohn Disease
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Feb 8, 2022

Knee Osteoarthritis Trial in Çorum (Nigella sativa oil, Naproxen and lidocaine gel, Massage)

Completed
  • Knee Osteoarthritis
  • Nigella sativa oil
  • +2 more
  • Çorum, Turkey
    Hitit University
Sep 12, 2022

Dysmotility Syndrome, Autoimmunity Trial in Baltimore (Current Intravenous Immunoglobulin (IVIG) treatment, No Intravenous

Recruiting
  • Dysmotility Syndrome
  • Autoimmunity
  • Current Intravenous Immunoglobulin (IVIG) treatment
  • No Intravenous Immunoglobulin (IVIG) treatment
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Mar 8, 2022

Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)

Enrolling by invitation
  • Interstitial Fibrosis
  • +6 more
  • Houston, Texas
    Houston Methodist Research Institute
Jan 23, 2023

Cognitive Impairment, Mild, Cognitive Dysfunction, Amyloid Plaque Trial in Phoenix, Las Vegas (Lenalidomide 10 mg, Placebo)

Recruiting
  • Cognitive Impairment, Mild
  • +4 more
  • Lenalidomide 10 mg
  • Placebo
  • Phoenix, Arizona
  • +1 more
Apr 14, 2022

Lymphoma Trial in United States (Tomivosertib (eFT-508))

Terminated
  • Lymphoma
  • Tomivosertib (eFT-508)
  • Los Angeles, California
  • +9 more
Oct 30, 2020

Pemphigus Vulgaris Trial in Changsha (recombinant human interleukin-2 (rhIL-2), )

Recruiting
  • Pemphigus Vulgaris
  • recombinant human interleukin-2 (rhIL-2)
  • placebo
  • Changsha, Hunan, China
    The Second Xiangya Hospital of Central South University
Jan 31, 2021

Primary Progressive Multiple Sclerosis Trial in Worldwide (Placebo, Laquinimod)

Completed
  • Primary Progressive Multiple Sclerosis
  • Phoenix, Arizona
  • +98 more
Mar 9, 2022

Immune Health Trial in Mumbai, Palghar, Thane (Aqueous extract of roots plus leaves of Withania somnifera 125 mg, Aqueous

Completed
  • Immune Health
  • Aqueous extract of roots plus leaves of Withania somnifera 125 mg
  • +2 more
  • Mumbai, Maharashtra, India
  • +2 more
Oct 18, 2021

Allergic Rhinitis Trial in Taipei City (AD17002, Formulation Buffer)

Completed
  • Allergic Rhinitis
  • AD17002
  • Formulation Buffer
  • Taipei City, Taiwan
    Taipei Medical University
Sep 13, 2021

Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of

Recruiting
  • Intracerebral Hemorrhage
  • +4 more
  • Fingolimod 0.5 mg
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Nov 28, 2022

Covid19, Respiratory Disease, Immune System Trial in Plovdiv (Viusid, Asbrip, Standard Care)

Completed
  • Covid19
  • +5 more
  • Viusid
  • +2 more
  • Plovdiv, Bulgaria
  • +1 more
Oct 20, 2021

Oral Ulceration Due to Behçet's Disease Trial (Rebamipide mouthwash, Betamethasone mouthwash)

Not yet recruiting
  • Oral Ulceration Due to Behçet's Disease
  • Rebamipide mouthwash
  • Betamethasone mouthwash
  • (no location specified)
Oct 13, 2023

COVID-19 Pneumonia Trial in Naples (Saisei Maf capsules)

Completed
  • COVID-19 Pneumonia
  • Saisei Maf capsules
  • Naples, Italy
    Ospedale del Mare Hospital
Sep 7, 2021

Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Oral Mucositis
  • Alfacalcidol Oral Solution
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Oral Mucositis Trial in Istanbul (coconut oil)

Not yet recruiting
  • Oral Mucositis
  • coconut oil
  • Istanbul, Turkey
    Başakşehir Çam and Sakura City Hospital
May 8, 2023